Skip to main content
Shanghai Hile Bio-Technology Co.,Ltd logo

Shanghai Hile Bio-Technology Co.,Ltd — Investor Relations & Filings

Ticker · 603718 ISIN · CNE1000022T4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,480 across all filing types
Latest filing 2025-08-27 Governance Information
Country CN China
Listing Shanghai Stock Exchange 603718

About Shanghai Hile Bio-Technology Co.,Ltd

http://www.hile-bio.com/

Shanghai Hile Bio-Technology Co., Ltd. specializes in the research, development, production, and distribution of veterinary biological products. The company focuses on providing comprehensive health solutions for the livestock and poultry sectors. Its core product portfolio includes a wide range of vaccines targeting major animal diseases, such as swine fever, porcine reproductive and respiratory syndrome (PRRS), foot-and-mouth disease, and various avian influenza strains. Utilizing advanced biotechnology and large-scale manufacturing processes, the company operates high-standard production facilities compliant with Good Manufacturing Practice (GMP) requirements. Hile Bio-Technology emphasizes innovation through its dedicated research and development centers, aiming to enhance animal disease prevention and control. The company serves large-scale farming enterprises and veterinary service providers, maintaining a significant presence in the animal health sector through its commitment to product quality and technical support.

Recent filings

Filing Released Lang Actions
海利生物股东会网络投票实施细则
Governance Information Classification · 95% confidence The document is titled as the "Implementation Rules for Online Voting at the Shareholders' Meeting" of Shanghai Haili Biotechnology Co., Ltd. It details the procedures, rules, and regulations for shareholders to participate in online voting during shareholder meetings. The content focuses on governance procedures related to shareholder meetings, voting methods, notification requirements, and vote counting. There is no financial data, earnings information, or audit content. It is not an announcement of voting results but rather the rules governing the voting process. This fits best under Governance Information (CGR), which covers internal rules and governance practices related to the company and its shareholder meetings.
2025-08-27 Chinese
海利生物关联交易实施细则
Governance Information Classification · 95% confidence The document is titled as "上海海利生物技术股份有限公司 关联交易实施细则" which translates to "Implementation Rules for Related Party Transactions of Shanghai Haili Biotechnology Co., Ltd.". The content is a detailed internal regulatory document outlining the principles, definitions, procedures, and disclosure requirements for related party transactions within the company. It references relevant laws and stock exchange rules but does not contain financial statements, audit results, earnings data, or any form of report publication announcement. It is a governance-related document specifying internal rules and compliance procedures for related party transactions. Therefore, it fits best under Governance Information (CGR). The document length is sufficient and it is not a brief announcement or certification, so it is not RPA or RNS.
2025-08-27 Chinese
海利生物信息披露暂缓与豁免业务内部管理制度
Governance Information Classification · 95% confidence The document is a detailed internal management system for information disclosure delay and exemption by Shanghai Haili Biotechnology Co., Ltd. It outlines procedures, responsibilities, and compliance with relevant laws and stock exchange rules. It is a governance-related document focusing on internal rules and processes for managing information disclosure, not a financial report, earnings release, or announcement. The document length is 3677 characters, which is relatively short and does not contain financial data or report content. It is not an announcement of a report publication but a governance policy document. Therefore, the most appropriate classification is Governance Information (CGR).
2025-08-27 Chinese
海利生物总经理工作细则
Governance Information Classification · 95% confidence The document is titled '总经理工作细则' which translates to 'General Manager Work Rules' or 'General Manager Work Regulations'. It details the responsibilities, appointment, and management structure related to the company's general manager and senior management. It includes governance and management procedures but does not contain financial data, audit results, or regulatory filings. It is a governance-related internal document outlining management roles and procedures, consistent with governance information about company internal rules and board/management structure. It is not an announcement, report, or financial statement. Therefore, the most appropriate classification is Governance Information (CGR).
2025-08-27 Chinese
海利生物董事会秘书工作制度
Governance Information Classification · 100% confidence The document is titled '董事会秘书工作制度' which translates to 'Board Secretary Work System' or 'Board Secretary Regulations'. It details the duties, qualifications, appointment, and responsibilities of the company's board secretary. It references relevant laws and regulations, the company's articles of association, and the role of the board secretary in governance and compliance. There is no financial data, no report of financial results, no announcement of voting results, no legal proceedings, no capital changes, or any other financial or regulatory filing content. The document is a governance-related internal rules and procedures document concerning the board secretary's role and responsibilities. Therefore, it fits best under Governance Information (CGR). The document length is 4078 characters, which is sufficient for a detailed governance document, not a brief announcement or notice.
2025-08-27 Chinese
海利生物独立董事专门会议工作细则
Governance Information Classification · 95% confidence The document is titled as "上海海利生物技术股份有限公司 独立董事专门会议工作细则" which translates to "Shanghai Haili Biotechnology Co., Ltd. Independent Directors Special Meeting Work Rules." The content details the rules, responsibilities, and procedures for independent directors' special meetings, including meeting frequency, voting, duties, confidentiality, and record-keeping. There is no financial data, no report of financial results, no announcement of voting results, no management changes, no legal proceedings, no capital updates, and no earnings information. The document is a governance-related internal regulation focusing on board structure and governance practices. Therefore, it fits best under Governance Information (CGR). The document length is 2058 characters, which is relatively short but contains substantive governance rules rather than an announcement or a brief note, so it is not an RPA or RNS.
2025-08-27 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.